Braveheart Financial Services, the boutique investment bank sold to Evercore for $50m (€39.2m) the day before it opened in August, has won its first mandate.

Braveheart is working alongside Lazard as financial adviser to UCB on the Belgian pharmaceutical group's recommended €4.4bn ($5.6bn) bid for German rival Schwarz Pharma, which was announced on Monday. Rothschild is working for the German company.